Dr. Sermer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-9920
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Duke University HospitalResidency, Internal Medicine, 2014 - 2017
Tufts University School of MedicineClass of 2014
Certifications & Licensure
MA State Medical License 2020 - 2025
NC State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 124 citationsCAR T-cell therapy: Full speed ahead.David Sermer, Renier J. Brentjens
Hematological Oncology. 2019-06-01 - 67 citationsOutcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.David Sermer, Connie L Batlevi, M. Lia Palomba, Gunjan L. Shah, Richard J. Lin
Blood Advances. 2020-10-13 - 80 citationsEmerging epigenetic-modulating therapies in lymphoma.David Sermer, Laura Pasqualucci, Hans-Guido Wendel, Ari Melnick, Anas Younes
Nature Reviews. Clinical Oncology. 2019-08-01
Journal Articles
- Oncology Drug Development and Approval of Systemic Anticancer Therapy by the US Food and Drug AdministrationMartell RE, Sermer D, Getz K, Kaitin K, The Oncologist, 2013
- Acrofacial Dysostosis Syndrome Type Rodriguez: Prenatal Diagnosis and Autopsy FindingsSermer D, Quercia N, Chong K, Chitayat D, American Journal of Medical Genetics, 2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
